0000950170-24-012167.txt : 20240207
0000950170-24-012167.hdr.sgml : 20240207
20240207160113
ACCESSION NUMBER: 0000950170-24-012167
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240205
FILED AS OF DATE: 20240207
DATE AS OF CHANGE: 20240207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ciulla Thomas
CENTRAL INDEX KEY: 0001815426
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36483
FILM NUMBER: 24604215
MAIL ADDRESS:
STREET 1: C/O CLEARSIDE BIOMEDICAL, INC.
STREET 2: 900 NORTH POINT PARKWAY, SUITE 200
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Viridian Therapeutics, Inc.\DE
CENTRAL INDEX KEY: 0001590750
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 471187261
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1215
BUSINESS ADDRESS:
STREET 1: 221 CRESCENT STREET
STREET 2: BLDG. 17, SUITE 401
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 617.272.4600
MAIL ADDRESS:
STREET 1: 221 CRESCENT STREET
STREET 2: BLDG. 17, SUITE 401
CITY: WALTHAM
STATE: MA
ZIP: 02453
FORMER COMPANY:
FORMER CONFORMED NAME: MIRAGEN THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20170213
FORMER COMPANY:
FORMER CONFORMED NAME: MIRAGEN THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20170213
FORMER COMPANY:
FORMER CONFORMED NAME: SIGNAL GENETICS, INC.
DATE OF NAME CHANGE: 20140710
4
1
ownership.xml
4
X0508
4
2024-02-05
0001590750
Viridian Therapeutics, Inc.\DE
VRDN
0001815426
Ciulla Thomas
C/O VIRIDIAN THERAPEUTICS, INC.
221 CRESCENT STREET, SUITE 401
WALTHAM
MA
02453
false
true
false
false
Chief Medical Officer
false
Stock Option (Right to Buy)
18.70
2024-02-05
4
A
false
50000
0.00
A
2034-02-05
Common Stock
50000
50000
D
The option vests in 48 equal monthly installments, subject to the Reporting Person's continued service to Issuer through each vesting date.
/s/ Thomas Ciulla
2024-02-07